News

GlobalData on MSN2d
Arch Biopartners’ Phase II AKI prevention trial begins patient recruitment
Arch Biopartners has initiated subject recruitment in its Phase II study aimed at assessing cilastatin’s efficacy in ...
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the ...
CN to Report Second-Quarter 2025 Financial and Operating Results Today
CN (TSX: CNR) (NYSE: CNI) will issue its second-quarter 2025 financial and operating results after the market close.
Why Ready-to-Eat, Home-Cooked Meals Are the Next Big Thing in Food Delivery: A TiffinStash Perspective
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
Stocktwits on MSN3d
ZenaTech’s ZenaDrone Subsidiary Applies for Green UAS Certification for IQ Square Drone to Sell to US Defense and Government
ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ('ZenaTech'), a business technology solution provider specializing in AI ...
Introducing REVENUE Brand: A Clothing Line Built for the Self-Made
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.